Breast cancer drug Avastin 'not effective' says Nice
A drug will not be available to treat breast cancer on the NHS
after it was unclear whether it improved survival rates, a watchdog said
In draft guidance, the National Institute for Health and Clinical Excellence (Nice) said it did not recommend Avastin (bevacizumab) for the treatment of breast cancer when used in combination with capecitabine (a type of chemotherapy).
Nice said that making Avastin available on the NHS was not a good use of resources because of its high cost, and the lack of evidence to show patients would have a better quality of life than if they were treated with chemotherapy alone.
Sir Andrew Dillon, chief executive of Nice, said: "We understand the need for effective treatments that can help patients live for as long as possible with a good quality of life. However, the evidence submitted to our independent appraisal committee did not conclusively show that bevacizumab could do either.
"The cost-effectiveness of the treatment was also an issue; we can't recommend a drug that has not been shown to work as well as, or better than, current treatments and costs much more.
"We want to ensure people have access to the best treatments the NHS can afford; bevacizumab has so far not been proven to be clinically or cost-effective."
A consultation has been opened for the drug's manufacturer, healthcare professionals and members of the public to comment on the guidance from Nice.
The charity Breakthrough Breast Cancer said the negative impact of using Avastin to treat cancer that has spread from where it started was unknown.
Dr Rachel Greig, senior policy officer at the organisation, said: "We welcome new treatments for women with metastatic breast cancer as we know their options are limited and prolonging life is incredibly important to them and their families.
"However, this treatment combination can cause serious side effects and there is no evidence to show how this may affect a patient's quality of life."
Life & Style blogs
Guest post by Richard Sexton, business development director of e.surv chartered surveyors
Plus lateral thinking and living on London's waterways
Other popular areas include Didsbury, Clifton in Bristol, central Cambridge and West Bridgford
Living with Google Glass: what are they actually like to wear?
Microsoft's Xbox One: Have the price (£399) and release date (30 November) been leaked by online retailer Zavvi?
Splint made by 3D printer used to save baby’s life
The 10 Best road-trip gadgets
Google Glass: First images taken on Google's new glasses appear on Twitter
- 1 Woolwich attack exclusive: Man in bloody video - named 'Mujahid' - was known to Anjem Choudary's banned Islamist group Al Muhajiroun
- 2 'Sickening, deluded and unforgivable': Horrific attack brings terror to London’s streets
- 3 Grace Dent: I’m not sure how these people can avoid being called ‘bigots’. And the more ‘civilised’, the worse they are
- 4 Ingrid Loyau-Kennett, the mother-of-two hailed as a hero for confronting Woolwich attackers, thought: 'better me than a child'
- 5 Woolwich attack: The EDL will seek to exploit this evil crime for their own evil ends
BMF is the UK’s biggest and best loved outdoor fitness classes
Find out what The Independent's resident travel expert has to say about one of the most beautiful small cities in the world
Win anything from gadgets to five-star holidays on our competitions and offers page.